EIGER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 28249U905. A total of 3 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 100 | -97.1% | 0.00% | – |
| Q2 2023 | $2 | -50.0% | 3,500 | -25.5% | 0.00% | – |
| Q1 2023 | $4 | -33.3% | 4,700 | -16.1% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 5,600 | +409.1% | 0.00% | – |
| Q3 2022 | $8,000 | -61.9% | 1,100 | -67.6% | 0.00% | – |
| Q2 2022 | $21,000 | -94.0% | 3,400 | -92.0% | 0.00% | – |
| Q1 2022 | $351,000 | +11600.0% | 42,300 | +6950.0% | 0.00% | – |
| Q4 2021 | $3,000 | -99.0% | 600 | -98.2% | 0.00% | – |
| Q3 2021 | $294,000 | +2.4% | 33,800 | 0.0% | 0.00% | – |
| Q2 2021 | $287,000 | -17.1% | 33,800 | +8522.4% | 0.00% | -100.0% |
| Q1 2021 | $346,000 | +73.0% | 392 | +140.5% | 0.00% | – |
| Q4 2020 | $200,000 | +4900.0% | 163 | +3160.0% | 0.00% | – |
| Q3 2020 | $4,000 | -42.9% | 5 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 180,100 | $1,534,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 33,800 | $287,000 | 0.00% |